This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
New Strong Sell Stocks for September 13th
by Zacks Equity Research
BGS, BRY, and CHUY have been added to the Zacks Rank #5 (Strong Sell) List on September 13, 2022.
B&G Foods (BGS) Looks Troubled: High Input Cost a Key Concern
by Zacks Equity Research
B&G Foods (BGS) expects to keep seeing significant cost inflation for inputs, such as ingredients, packaging, labor and transportation.
New Strong Sell Stocks for August 26th
by Zacks Equity Research
BBBY, ALCO, and BGS have been added to the Zacks Rank #5 (Strong Sell) List on August 26, 2022.
General Mills (GIS) Accelerate Strategy Solid, Costs Inflated
by Zacks Equity Research
General Mills (GIS) has been gaining from its Accelerate strategy and focus on key priorities. These bode well amid the rising cost inflation.
B&G Foods (BGS) Cuts View as Q2 Earnings Miss on Cost Inflation
by Zacks Equity Research
B&G Foods' (BGS) second-quarter fiscal 2022 results reflect gains from high demand and pricing actions, whereas the escalated input cost inflation hurts earnings. The company lowers the adjusted EPS view.
B&G Foods (BGS) Q2 Earnings Lag Estimates
by Zacks Equity Research
B&G Foods (BGS) delivered earnings and revenue surprises of -74.07% and 0%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is B&G Foods (BGS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
B&G Foods (BGS) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Higher product demand and a solid brand portfolio are likely to aid B&G Foods' (BGS) second-quarter 2022 results. However, cost inflation is a major headwind.
Vital Farms (VITL) Moves 16.1% Higher: Will This Strength Last?
by Zacks Equity Research
Vital Farms (VITL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
B&G Foods (BGS) Down 15% in 3 Months: High Costs a Key Reason
by Zacks Equity Research
B&G Foods (BGS) expects to keep seeing significant cost inflation for inputs, such as ingredients, packaging and transportation, in fiscal 2022.
B&G Foods' (BGS) New Business Unit Structure to Boost Growth
by Zacks Equity Research
B&G Foods (BGS) is forming four business units, Spices & Seasonings, Meals, Frozen & Vegetables and Specialty.
Exxon Mobil and B&G Foods have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Exxon Mobil and B&G Foods are part of Zacks Bull and Bear of the Day article.
B&G Foods (BGS) Troubled by Cost Inflation, Supply-Chain Woes
by Zacks Equity Research
B&G Foods (BGS) has been encountering industry-wide inflation in input costs and supply-chain bottlenecks. Management cuts its adjusted EBITDA and EPS forecast due to cost inflation.
Bear of the Day: B&G Foods (BGS)
by Tracey Ryniec
Cost inflation is hitting the maker of Green Giant.
New Strong Sell Stocks for May 9th
by Zacks Equity Research
AXAHY, BGS, and AAGIY have been added to the Zacks Rank #5 (Strong Sell) List on May 9, 2022.
B&G Foods (BGS) Q1 Earnings Miss Estimates, EPS View Lowered
by Zacks Equity Research
B&G Foods' (BGS) first-quarter fiscal 2022 results reflect gains from high demand and pricing actions, whereas the escalated input cost inflation hurts margins.
B&G Foods (BGS) Q1 Earnings Lag Estimates
by Zacks Equity Research
B&G Foods (BGS) delivered earnings and revenue surprises of -12.82% and 4.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The J.M. Smucker (SJM) Gains on Demand Amid Cost Hurdles
by Zacks Equity Research
The J.M. Smucker (SJM) has been gaining on the revival in away from home demand and its focus on core priorities, while cost headwinds have been a concern.
Medifast (MED) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 0.84% and 0.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
B&G Foods' (BGS) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
B&G Foods' (BGS) first-quarter 2022 performance will likely reflect gains from higher demand and strategic buyouts. However, escalated cost inflation is a concern.
Earnings Preview: B&G Foods (BGS) Q1 Earnings Expected to Decline
by Zacks Equity Research
B&G Foods (BGS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
B&G Foods (BGS) Down 8.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
B&G Foods (BGS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
B&G Foods (BGS) Stock Declines 13% YTD on Cost Inflation
by Vrishali Bagree
B&G Foods (BGS) is encountering escalated cost concerns. Management expects to keep seeing significant cost inflation for inputs, such as ingredients, packaging and transportation.
Mondelez (MDLZ) Well Poised on Brand Strength Amid Cost Woes
by Zacks Equity Research
Mondelez International (MDLZ) has been benefiting from its prudent acquisitions. Also, its pricing and saving strategies are helping amid an inflationary cost environment.
New Strong Sell Stocks for March 14th
by Zacks Equity Research
AVYA, BGS, and CMMB have been added to the Zacks Rank #5 (Strong Sell) List on March 14, 2022.